MedicinesFAQ

PF-04691502

PF-04691502 Uses, Dosage, Side Effects, Food Interaction and all others data.

PF-04691502 has been used in trials studying the treatment of Cancer, Breast Neoplasms, Early Breast Cancer (Phase 2), and Advanced Breast Cancer (Phase 1b).

Trade Name	PF-04691502
Generic	PF-04691502
Type
Formula	C₂₂H₂₇N₅O₄
Weight	Average: 425.4809 Monoisotopic: 425.206304377
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Innovators Monograph

You find simplified version here PF-04691502

Content Sources

https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=25033539
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=347828297
https://www.chemspider.com/Chemical-Structure.24774910.html
http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50380313
https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL1234354
https://zinc.docking.org/substances/ZINC000117704832
https://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/ML9

*** Taking medicines without doctor's advice can cause long-term problems.

Download Bissoy app from Play Store to get doctor's consultation over video call